Previous clinical studies attempting to define p53 staining as a surrogate to predict mutations in BC have relied on the OE and/or CA staining pattern, which have yielded different cut-off values, ranging from 10 to 50% positive cells, or CA only [4, 6, 16, 18, 22]. The gene discussed is TP53; the disease is breast cancer.